-
PELOBIOTECH GmbH announces collaboration with HVD Life Science Vertriebs GmbH to bring revolutionary Poietis’ Next-Gen Bioprinting platform, NGB-RTM t
PELOBIOTECH GmbH, a leader in the field of biotechnology, announces a strategic partnership with HVD Life Science Vertriebs GmbH to distribute the innovative Poietis’ Next-Gen Bioprinting platform, NGB-RTM in Germany. This strategic partnership is anticipated to set new standards in the field of biotechnological research, providing scientists and researchers in Germany with access to state-of-the-art bioprinting technology. The Poietis’ NGB-R™ platform is expected to play a crucial role in advancing research in tissue engineering, regenerative medicine, and drug discovery, among other areas. Dr. Peter Frost, CEO of PELOBIOTECH, expressed his passion for the partnership, stating, “Our alliance with HVD Life Science Vertriebs GmbH represents a significant leap forward not only…
-
First Conference “Advancements in Animal-Free Research and Translational Medicine” in Munich
PELOBIOTECH GmbH is happy to announce organizing the first conference "Advancements in Animal-Free Research and Translational Medicine" in Munich/Gräfelfing. Scheduled for June 27, 2024, this conference aims to spotlight novel non-animal approaches vital for progress in translational medical research. The Munich Cell Specialist PELOBIOTECH distributes one of the broadest portfolios of 2D&3D cell culture systems, cell culture products and media. The conference will start with an overview of the development and validation of serum substitutes. “Paving the way for ethically sound alternatives is crucial today for scientific advancements”, said Dr. Lothar Steeb, Co-CEO&CSO PELOBiotech. In addition to getting insights on the principles of cell culture and stem cells, presentations will…
-
PELOBiotech stellt CellCorTM Linie auf der ATMP Tagung vor.
Mit dem Thema „Advanced Therapies – Challenges for Routine Applications“ startet am 17.5.2022 die ATMP im Haus der DECHEMA in Frankfurt. Als einer der weltweit führenden Anbieter tierischer und humaner Zellen & Medien präsentiert das Unternehmen PELOBiotech, aus Planegg bei München, die CellCorTM Linie. Diese, seit knapp einem Jahr in Europa eingeführte, chemisch definierte Medium-Linie der koreanischen Xcell Therapeutics, eignet sich hervorragend für mesenchymale Stammzellen (MSCs) und ist als chemisch definiertes MSC-Medium CellCorTM CD erhältlich. Durch das Angebot dieses neuen Produkts treibt das Unternehmen die Stammzellenforschung weit nach vorne. Zudem stellt PELOBiotech weitere chemisch definierte Medien der Premium-Eigenmarke von PELOBiotech Cellovations® vor, die für die EV-freie Forschung und Produktion geeignet…
-
PELOBiotech: Biopolymer inspired by spider silk for 3D Cell Culture, Bioprinting and Cultured Meat
Martinsried – PELOBiotech GmbH, one of the leading Cell Culture solution experts worldwide, is happy to introduce SpheroSeev & HydroSeev, recombinant biopolymers similar to spider silk. They are produced by Seevix, an Israelian biotech company, and can be used together with hydrogels (e.g. Matrigel) to stabilize hydrogels for long-term culture. “As the need for long-term cell culture is rising and consistent and reproducible results are needed,” says Dr. Peter Frost, CEO PELOBiotech, “we are happy to ease the path for this easy, outstanding solution to the European scientific community.“ Therefore PELOBiotech is strengthening its position as 3D cell culture specialist and widening its broad portfolio of solution-demanded 3D cell culture…
